Adicet Bio, Inc. Deferred Tax Assets, Deferred Income
Adicet Bio, Inc. (ACET) had Deferred Tax Assets, Deferred Income of $0 as of 2023-12-31, per its 10-K filed 2024-03-19.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsDeferredIncome · last filed 2024-03-19
- 2023-12-31: Deferred Tax Assets, Deferred Income $0.00.
- 2022-12-31: Deferred Tax Assets, Deferred Income $0.00.
- 2021-12-31: Deferred Tax Assets, Deferred Income $1.26M.
- 2020-12-31: Deferred Tax Assets, Deferred Income $2.86M.
| Period end | Deferred Tax Assets, Deferred Income |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-19 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-19 |
| 2021-12-31 | $1.26M 10-K · filed 2023-03-15 |
| 2020-12-31 | $2.86M 10-K · filed 2022-03-15 |
| 2019-12-31 | $5.72M 10-K · filed 2021-03-12 |
| 2018-12-31 | $5.13M 10-K · filed 2021-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |